Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
HALMED · 9 medicines
FDA · 8 medicines
AEMPS · 6 medicines
Anvisa · 5 medicines
MS · 4 medicines · Historical list
ALIMS · 3 medicines
SFDA · 3 medicines · Historical list
EMA · 2 medicines
AIFA · 1 medicine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
8 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Tofacitinib | United States | 10MG, 5MG | tablet | Tentative approval | Annora Pharma Private Limited |
| Tofacitinib | United States | 10MG, 5MG | tablet | Tentative approval | Prinston Pharma INC |
| Tofacitinib Citrate | United States | 11MG BASE, 22MG, 22MG BASE | tablet, extended release | Marketed | Zydus Pharms |
| Tofacitinib Citrate | United States | 10MG BASE, 5MG BASE | tablet | Marketed | Aurobindo Pharma LTD |
| Tofacitinib Citrate | United States | 1MG BASE/ML | solution | Marketed | Sun Pharm Inds INC |
| Xeljanz | United States | 10MG BASE, 5MG BASE | tablet | Marketed | PF Prism CV |
| Xeljanz | United States | 1MG BASE/ML | solution | Marketed | Pfizer |
| Xeljanz XR | United States | 11MG BASE, 22MG BASE | tablet, extended release | Marketed | Pfizer |
The same brand on several registers.
The companies holding its medicines, the most first.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, Anvisa, CBG-MEB, EMA, FDA, HALMED, Health Canada, HSA, MS and SFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
